National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
RIBAVIRIN AND INTERFERON COMBINA
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| REBETRON 600 | 1F095 | A | 3 | 2 | 4 | ZZ | ||
| 02-0539 | 89875 | A | 5 | 1 | 4 | ZZ | ||
| 6505NCM010332 | 64616 | A | 5 | 1 | 4 | ZZ | ||
| NDC00085-1236-03 | 1F095 | A | 3 | 2 | 4 | ZZ |
CAGE Information
| Code | Company |
|---|---|
| 1F095 | SCHERING-PLOUGH CORPORATION |
| 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE |
| 64616 | DEFENSE MEDICAL STANDARDIZATION BOAR |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | RIBAVIRIN & INTERFERON COMBINATION PACK |
| AGAV | END ITEM IDENTIFICATION | FOR THE TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH COMPENSATED LIVER DISEASE PREVIOUSLY UNTREATED WITH ALPHA INTERFERON OR WHO HAVE RELAPSED FOLLOWING ALPHA INTERFERON THERAPY |
| FEAT | SPECIAL FEATURES | 1 UNIT DOSE VIAL OF INTERFERON ALPHA-2B, 3 MILLION UNITS/0.5ML, 18 MILLION UNITS/VIALS; 42 CAPSULES OF RIBAVIRIN, 200 MG CAPSULE; INTERFERON SHOULD BE ADMINISTERED SUBCUTANEOUSLY AND RIBAVIRIN CAPSULES SHOULD BE ADMINISTERED ORALLY; REFRIGERATE RIBAVIRIN CAPSULES AND INTERFERON PACKAGE BETWEEN 2 AND 8 DEGREES C (36 AND 46 DEGREES F) |